Literature DB >> 18327556

Influence of a reduced CO2 environment on the secretion yield, potency and N-glycan structures of recombinant thyrotropin from CHO cells.

João Ezequiel Oliveira1, Renata Damiani, Karola Vorauer-Uhl, Paolo Bartolini, Maria Teresa C P Ribela.   

Abstract

A consistent increase of approximately 60% in the secretion yield of CHO-derived hTSH was observed by changing cell culture CO2 conditions from 5% CO2 to an air environment. The overall quality of the products obtained under both conditions was evaluated in comparison with a well-known biopharmaceutical (Thyrogen). The N-glycans identified were of the complex type, presenting di-, tri- and tetra-antennary structures, sometimes fucosylated, 86-88% of the identified structures being sialylated at variable levels. The three most abundant structures were monosialylated glycans, representing approximately 69% of all identified forms in the three preparations. The main difference was found in terms of antennarity, with 8-10% more di-antennary structures obtained in the absence of CO2 and 7-9% more tri-antennary structures in its presence. No remarkable difference in charge isomers was observed between the three preparations, the isoelectric focusing profiles showing six distinct bands in the 5.39-7.35 pI range. A considerably different distribution, with more forms in the acidic region, was observed, however, for two native pituitary preparations. All recombinant preparations showed a higher in vivo bioactivity when compared to native hTSH. Different production processes apparently do not greatly affect N-glycan structures, charge isomer distribution or bioactivity of CHO-derived hTSH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327556     DOI: 10.1007/s12033-008-9047-6

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  37 in total

1.  Two-step chromatographic purification of recombinant human thyrotrophin and its immunological, biological, physico-chemical and mass spectral characterization.

Authors:  Fernanda de Mendonça; João Ezequiel de Oliveira; Paolo Bartolini; Maria Teresa C P Ribela
Journal:  J Chromatogr A       Date:  2005-01-07       Impact factor: 4.759

2.  The use of recombinant human thyrotropin produced by Chinese hamster ovary cells for the preparation of immunoassay reagents.

Authors:  M T Ribela; A C Bianco; P Bartolini
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

3.  Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells.

Authors:  Kornelia Schriebl; Evelyn Trummer; Christine Lattenmayer; Robert Weik; Renate Kunert; Dethardt Müller; Hermann Katinger; Karola Vorauer-Uhl
Journal:  Protein Expr Purif       Date:  2006-06-15       Impact factor: 1.650

4.  N-linked oligosaccharide analysis of glycoprotein bands from isoelectric focusing gels.

Authors:  Qun Zhou; Sung-Hae Park; Susan Boucher; Elizabeth Higgins; Karen Lee; Tim Edmunds
Journal:  Anal Biochem       Date:  2004-12-01       Impact factor: 3.365

5.  The asparagine-linked oligosaccharides at individual glycosylation sites in human thyrotrophin.

Authors:  J Hiyama; G Weisshaar; A G Renwick
Journal:  Glycobiology       Date:  1992-10       Impact factor: 4.313

6.  Recombinant human thyroid stimulating hormone: development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma.

Authors:  E S Cole; K Lee; K Lauziere; C Kelton; S Chappel; B Weintraub; D Ferrara; P Peterson; R Bernasconi; T Edmunds
Journal:  Biotechnology (N Y)       Date:  1993-09

Review 7.  The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties.

Authors:  C F Goochee; M J Gramer; D C Andersen; J B Bahr; J R Rasmussen
Journal:  Biotechnology (N Y)       Date:  1991-12

8.  Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. I. Structural elucidation of the sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones.

Authors:  E D Green; J U Baenziger
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

9.  A novel, nonradioactive in vivo bioassay of thyrotropin (TSH).

Authors:  J East-Palmer; M W Szkudlinski; J Lee; N R Thotakura; B D Weintraub
Journal:  Thyroid       Date:  1995-02       Impact factor: 6.568

10.  Enhancement of recombinant erythropoietin production in CHO cells in an incubator without CO(2) addition.

Authors:  S K Yoon; Y H Ahn; K Han
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

View more
  3 in total

1.  Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity.

Authors:  Yoshinobu Konno; Yuki Kobayashi; Ken Takahashi; Eiji Takahashi; Shinji Sakae; Masako Wakitani; Kazuya Yamano; Toshiyuki Suzawa; Keiichi Yano; Toshio Ohta; Masamichi Koike; Kaori Wakamatsu; Shinji Hosoi
Journal:  Cytotechnology       Date:  2011-08-27       Impact factor: 2.058

2.  Evaluation of a glycoengineered monoclonal antibody via LC-MS analysis in combination with multiple enzymatic digestion.

Authors:  Renpeng Liu; John Giddens; Colleen M McClung; Paula E Magnelli; Lai-Xi Wang; Ellen P Guthrie
Journal:  MAbs       Date:  2015-10-29       Impact factor: 5.857

3.  N-Glycoprofiling Analysis for Carbohydrate Composition and Site-Occupancy Determination in a Poly-Glycosylated Protein: Human Thyrotropin of Different Origins.

Authors:  Maria Teresa C P Ribela; Renata Damiani; Felipe D Silva; Eliana R Lima; João E Oliveira; Cibele N Peroni; Peter A Torjesen; Carlos R Soares; Paolo Bartolini
Journal:  Int J Mol Sci       Date:  2017-02-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.